US › Healthcare

CVRx Inc (CVRX)

US · Healthcare · Medical Devices

$3.00-0.66%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$15.7M

Revenue YoY

+15.6%

Net profit

$-14.0M

EPS

$-0.53

EPS estimate

$-0.52

Net margin

-89.4%

EPS came in at -0.53 against a street estimate of -0.52 — a miss of 1.9%.

Key statistics

Market cap

$76.7M

Forward P/E

0.0

P/B

3.85

Book value

$0.75

EPS (TTM)

$-1.97

52-week high

$11.30

52-week low

$2.20

50-day MA

$4.08

200-day MA

$6.38

Beta

0.76

Analyst view

Analysts rate CVRx Inc a strong buy (6 buy, 1 hold, 0 sell out of 7) with an average price target of $4.58.

Shareholding

Insiders

15.20%

Institutions

65.81%

Largest institutional holders

Fund	Stake
Johnson & Johnson	15.11%
NEA Management Company, LLC	7.61%
BlackRock Inc	3.85%
GSK PLC	3.78%
Vanguard Capital Management, LLC	3.42%
Royal Bank of Canada	2.65%
Balyasny Asset Management LLC	2.37%
Silvercrest Asset Management Group LLC	2.15%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CVRx Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.